Abstract
Background and Aims: Aim: Diagnostic tools for familial hypercholesterolemia (FH), including the Dutch Lipid Clinic Criteria (DLCC), British Simon Broome (SB) and the US Make Early Diagnosis to Prevent Early Deaths (US MEDPED) criteria, are used to identify FH patients. However, their diagnostic outcomes may not be in agreement with each other. Furthermore, the agreement between those criteria is unclear in the Asian population. This study aimed to investigate the agreement between these criteria in an Asian population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
